Notice of Intent: Bio-Rad QX200 Droplet Digital PCR (ddPCR) System.
\n\n(75N98026Q01194)
\n\nThe National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Bio-rad Laboratories, Inc. under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
\n\nThe National Institutes of Health (NIH), [Institute/Center], intends to solicit and negotiate on a sole-source basis with Bio-rad Laboratories, Inc. for the acquisition of Bio-Rad QX200 Droplet Digital PCR (ddPCR) System.
\n\nBio-Rad Laboratories is the sole manufacturer and provider of the QX200 ddPCR system and its proprietary droplet-based digital PCR technology. The system employs a unique microfluidic droplet partitioning approach that enables absolute quantification of nucleic acid targets with high precision and sensitivity.
\n\nNo alternative commercially available system provides the specific combination of capabilities.
\n\nThis notice is not a request for competitive quotations. However, any responsible source, including small business concerns (e.g., 8(a), HUBZone, Service-Disabled Veteran-Owned Small Business, Veteran-Owned Small Business, Women-Owned Small Business, and Small Disadvantaged Business), that believes it can satisfy the Government's requirement may submit a capability statement demonstrating its ability to provide a product that meets the Government's minimum technical requirements. Capability statements must include sufficient documentation to establish the ability to furnish an equivalent system.
\n\nA determination by the Government not to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the Government.
\n\nResponses must be submitted via email to vensonm@mail.nih.gov no later than 9:00 a.m. EDT on September 17, 2026. It is anticipated that an award will be issued approximately five (5) days after the closing date of this notice, provided no acceptable capability statements are received.
","text":"Notice of Intent: Bio-Rad QX200 Droplet Digital PCR (ddPCR) System.\n\n(75N98026Q01194)\n\nThe National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Bio-rad Laboratories, Inc. under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.\n\nThe National Institutes of Health (NIH), [Institute/Center], intends to solicit and negotiate on a sole-source basis with Bio-rad Laboratories, Inc. for the acquisition of Bio-Rad QX200 Droplet Digital PCR (ddPCR) System.\n\nBio-Rad Laboratories is the sole manufacturer and provider of the QX200 ddPCR system and its proprietary droplet-based digital PCR technology. The system employs a unique microfluidic droplet partitioning approach that enables absolute quantification of nucleic acid targets with high precision and sensitivity.\n\nNo alternative commercially available system provides the specific combination of capabilities.\n\nThis notice is not a request for competitive quotations. However, any responsible source, including small business concerns (e.g., 8(a), HUBZone, Service-Disabled Veteran-Owned Small Business, Veteran-Owned Small Business, Women-Owned Small Business, and Small Disadvantaged Business), that believes it can satisfy the Government's requirement may submit a capability statement demonstrating its ability to provide a product that meets the Government's minimum technical requirements. Capability statements must include sufficient documentation to establish the ability to furnish an equivalent system.\n\nA determination by the Government not to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the Government.\n\nResponses must be submitted via email to vensonm@mail.nih.gov no later than 9:00 a.m. EDT on September 17, 2026. It is anticipated that an award will be issued approximately five (5) days after the closing date of this notice, provided no acceptable capability statements are received.","origin":"detail"},"notice_type":{"code":"p","label":"Presolicitation"},"schema_version":1,"solicitation_number":"75N98026Q01194","place_of_performance":{"zip":"20892","city":{"code":"7125","name":"Bethesda"},"state":{"code":"MD","name":"Maryland"},"country":{"code":"USA","name":"UNITED STATES"}},"product_service_code":"6640"}],"due_at":"2026-09-17T13:00:00Z","due_date":"2026-09-17","closes_at":"2026-09-17T13:00:00Z","awardable":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N980","office_name":"NATIONAL INSTITUTES OF HEALTH OLAO","state":"MD","country":"USA","winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T07:31:38.954589Z","principal_notice_id":"ba5108b779464df2a3ed8ba779644821","description":{"text":"Notice of Intent: Bio-Rad QX200 Droplet Digital PCR (ddPCR) System.\n\n(75N98026Q01194)\n\nThe National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Bio-rad Laboratories, Inc. under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.\n\nThe National Institutes of Health (NIH), [Institute/Center], intends to solicit and negotiate on a sole-source basis with Bio-rad Laboratories, Inc. for the acquisition of Bio-Rad QX200 Droplet Digital PCR (ddPCR) System.\n\nBio-Rad Laboratories is the sole manufacturer and provider of the QX200 ddPCR system and its proprietary droplet-based digital PCR technology. The system employs a unique microfluidic droplet partitioning approach that enables absolute quantification of nucleic acid targets with high precision and sensitivity.\n\nNo alternative commercially available system provides the specific combination of capabilities.\n\nThis notice is not a request for competitive quotations. However, any responsible source, including small business concerns (e.g., 8(a), HUBZone, Service-Disabled Veteran-Owned Small Business, Veteran-Owned Small Business, Women-Owned Small Business, and Small Disadvantaged Business), that believes it can satisfy the Government's requirement may submit a capability statement demonstrating its ability to provide a product that meets the Government's minimum technical requirements. Capability statements must include sufficient documentation to establish the ability to furnish an equivalent system.\n\nA determination by the Government not to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the Government.\n\nResponses must be submitted via email to vensonm@mail.nih.gov no later than 9:00 a.m. EDT on September 17, 2026. It is anticipated that an award will be issued approximately five (5) days after the closing date of this notice, provided no acceptable capability statements are received.","html":"Notice of Intent: Bio-Rad QX200 Droplet Digital PCR (ddPCR) System.
\n\n(75N98026Q01194)
\n\nThe National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Bio-rad Laboratories, Inc. under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
\n\nThe National Institutes of Health (NIH), [Institute/Center], intends to solicit and negotiate on a sole-source basis with Bio-rad Laboratories, Inc. for the acquisition of Bio-Rad QX200 Droplet Digital PCR (ddPCR) System.
\n\nBio-Rad Laboratories is the sole manufacturer and provider of the QX200 ddPCR system and its proprietary droplet-based digital PCR technology. The system employs a unique microfluidic droplet partitioning approach that enables absolute quantification of nucleic acid targets with high precision and sensitivity.
\n\nNo alternative commercially available system provides the specific combination of capabilities.
\n\nThis notice is not a request for competitive quotations. However, any responsible source, including small business concerns (e.g., 8(a), HUBZone, Service-Disabled Veteran-Owned Small Business, Veteran-Owned Small Business, Women-Owned Small Business, and Small Disadvantaged Business), that believes it can satisfy the Government's requirement may submit a capability statement demonstrating its ability to provide a product that meets the Government's minimum technical requirements. Capability statements must include sufficient documentation to establish the ability to furnish an equivalent system.
\n\nA determination by the Government not to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the Government.
\n\nResponses must be submitted via email to vensonm@mail.nih.gov no later than 9:00 a.m. EDT on September 17, 2026. It is anticipated that an award will be issued approximately five (5) days after the closing date of this notice, provided no acceptable capability statements are received.
","origin":"detail"},"contacts":[{"name":"MAI VENSON","role":"primary","email":"vensonm@mail.nih.gov"}],"place_of_performance":{"zip":"20892","city":{"code":"7125","name":"Bethesda"},"state":{"code":"MD","name":"Maryland"},"country":{"code":"USA","name":"UNITED STATES"}},"office_address":{"zip":"20892","city":"BETHESDA","state":"MD","country":"USA"},"naics_codes":["334516"],"award":null,"attachments":[],"awards":[],"related":[{"key":"75N98026Q01157","latest_notice_id":"b8edf08457d54b63b193016f93f958f5","title":"Alamar ARGO HT System","solicitation_number":"75N98026Q01157","notice_type":"k","first_type":"k","first_posted":"2026-09-08","last_posted":"2026-09-08","notices":1,"due_at":"2026-09-17T13:00:00Z","due_date":"2026-09-17","closes_at":"2026-09-17T13:00:00Z","awardable":true,"open":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N980","office_name":"NATIONAL INSTITUTES OF HEALTH OLAO","naics":"334516","psc":"6640","set_aside":"SBA","state":"MD","country":"USA","winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T07:31:38.954589Z"},{"key":"75N98026Q01161","latest_notice_id":"a4abdfd8fbd84a77ab8c0418488df809","title":"Miltenyi Biotec for a gentleMACS™ Octo Dissociator with Heaters.","solicitation_number":"75N98026Q01161","notice_type":"p","first_type":"p","first_posted":"2026-09-08","last_posted":"2026-09-08","notices":1,"due_at":"2026-09-17T13:00:00Z","due_date":"2026-09-17","closes_at":"2026-09-17T13:00:00Z","awardable":true,"open":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N980","office_name":"NATIONAL INSTITUTES OF HEALTH OLAO","naics":"334516","psc":"6640","set_aside":null,"state":"MD","country":"USA","winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T07:31:38.954589Z"},{"key":"75N98026Q01162","latest_notice_id":"407324c6677c4deb8a4f37ee5646f09c","title":"LI-COR Biosciences (LICORbio) for an Odyssey® M Imager","solicitation_number":"75N98026Q01162","notice_type":"p","first_type":"p","first_posted":"2026-09-08","last_posted":"2026-09-08","notices":1,"due_at":"2026-09-17T13:00:00Z","due_date":"2026-09-17","closes_at":"2026-09-17T13:00:00Z","awardable":true,"open":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N980","office_name":"NATIONAL INSTITUTES OF HEALTH OLAO","naics":"334516","psc":"6640","set_aside":null,"state":"MD","country":"USA","winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T07:31:38.954589Z"},{"key":"75N98026Q01207","latest_notice_id":"00b90065c7454f2ebcc55d01e377637a","title":"Specialized Clinical Laboratory Testing Services","solicitation_number":"75N98026Q01207","notice_type":"p","first_type":"p","first_posted":"2026-09-12","last_posted":"2026-09-12","notices":1,"due_at":"2026-09-17T13:00:00Z","due_date":"2026-09-17","closes_at":"2026-09-17T13:00:00Z","awardable":true,"open":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N980","office_name":"NATIONAL INSTITUTES OF HEALTH OLAO","naics":"541380","psc":"Q301","set_aside":null,"state":"MD","country":"USA","winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T07:31:38.954589Z"},{"key":"NCISBSSCTEPESYS0001","latest_notice_id":"53912490fe424fd7a9e11fdaaf6a22a4","title":"NCI Oncology Clinical Trial System, Management and Support","solicitation_number":"NCI-SBSS-CTEP-ESYS-0001","notice_type":"r","first_type":"r","first_posted":"2026-09-03","last_posted":"2026-09-03","notices":1,"due_at":"2026-09-17T19:00:00Z","due_date":"2026-09-17","closes_at":"2026-09-17T19:00:00Z","awardable":true,"open":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N980","office_name":"NATIONAL INSTITUTES OF HEALTH OLAO","naics":"541512","psc":null,"set_aside":null,"state":"MD","country":"USA","winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T07:31:38.954589Z"}]}